Clinical trial
A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low…
NCT00175032 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00175032 |
|---|---|
| Title | A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin |
| Official title | A Randomized, Double-Blind, Phase 3 Study to Compare the Efficacy and Safety of Lansoprazole 30 mg QD and Naproxen 500 mg BID Versus Celecoxib 200 mg QD in Risk Reduction of Non Steroidal Anti-Inflammatory-Associated Ulcers in Osteoarthritis Subjects Taking Low Dose Aspirin |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Peptic Ulcer |
| Intervention type | Drug |
| Interventions | Lansoprazole and naproxen and aspirin, Celecoxib and aspirin |
| Enrollment | 1,045 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 22, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: